prazosin has been researched along with Kidney Stones in 2 studies
Prazosin: A selective adrenergic alpha-1 antagonist used in the treatment of HEART FAILURE; HYPERTENSION; PHEOCHROMOCYTOMA; RAYNAUD DISEASE; PROSTATIC HYPERTROPHY; and URINARY RETENTION.
prazosin : A member of the class of piperazines that is piperazine substituted by a furan-2-ylcarbonyl group and a 4-amino-6,7-dimethoxyquinazolin-2-yl group at positions 1 and 4 respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oestreich, MC | 1 |
| Vernooij, RW | 1 |
| Sathianathen, NJ | 1 |
| Hwang, EC | 1 |
| Kuntz, GM | 1 |
| Koziarz, A | 1 |
| Scales, CD | 1 |
| Dahm, P | 1 |
| Yang, TX | 1 |
| Liao, BH | 1 |
| Chen, YT | 1 |
| Li, H | 1 |
| He, Q | 1 |
| Liu, QY | 1 |
| Wang, KJ | 1 |
2 reviews available for prazosin and Kidney Stones
| Article | Year |
|---|---|
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; D | 2020 |
A network meta-analysis on the beneficial effect of medical expulsive therapy after extracorporeal shock wave lithotripsy.
Topics: Adrenergic alpha-1 Receptor Antagonists; Calcium Channel Blockers; Combined Modality Therapy; Humans | 2017 |